Pain medicine

Effect of transversus abdominis plane block versus intravenous hydromorphone on the quality of postoperative recovery in elderly critically Ill patients in the SICU: a single-center, single-blind, randomised controlled trial

Perioper Med (Lond)Published Randomised controlled trial

Authors' conclusion

TAP block significantly improves recovery quality and provides better analgesia than hydromorphone in elderly critically ill patients after major abdominal surgery, reducing opioid use and enhancing postoperative outcomes.

Study context

Population
Elderly critically ill patients after major abdominal surgery in the Surgical ICU with postoperative pain (VAS ≥ 4), Jiaxing First Hospital, July 2024 to December 2025122 completed
Participants
61 vs 61
Comparison
Ultrasound-guided TAP block vs IV hydromorphone
  • TAPn = 61
  • Controln = 61reference
Primary endpoint
Quality of Recovery-40 (QoR-40) score
Follow-up
24 h postoperatively
Methodological detailsprospective, single-blind, single-centre
  • Prospective
  • Single-blind
  • Single-centre

Primary result

As reported in the abstract

QoR-40 score · 24 h

TAP

170

median · IQR 167–172

Control

157

median · IQR 153–158

P < 0.001

Secondary outcomes

Median

OutcomeTAPControlP value
QoR-40 score · 48 hAbstract states significantly higher in TAP162 (IQR 159,165)171 (IQR 169,174)P < 0.001
  • QoR-40 score: values in the order printed; inconsistent with the stated direction

VAS scores and opioid consumption

Lower VAS scores and reduced opioid consumption in TAP vs Control

Original publication

Effect of transversus abdominis plane block versus intravenous hydromorphone on the quality of postoperative recovery in elderly critically Ill patients in the SICU: a single-center, single-blind, randomised controlled trial. Perioper Med (Lond). Published 27 November 2025. doi:10.1186/s13741-025-00630-9

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.